Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

Original article

logo “Strategy of optimization until 2035”

Im ersten Teil des MVF-Fachkongresses „Priorisierungskatalog Versorgungsforschung“, der am 13. Dezember 2022 online stattfand, mahnte Prof. Josef Hecken, unparteiischer Vorsitzender des G-BA und gleichzeitig Vorsitzender des beim G-BA angesiedelten Innovationsausschusses, eine „kritische Reflexion“ des Innovationsfonds an. Die startete „Monitor Versorgungsforschung“ mit dem zweiten Teil des Onlinekongresses, der am 24. Januar 2023 durchgeführt wurde. Hier kamen […]

02.04.2023
logo VBHC: Does it work? Yes! Is it easy? No!

White paper Value Based Healthcare from Janssen

02.04.2023
logo From stroke guide to patient guide

STROKE OWL becomes LEX LOTSEN OWL

02.04.2023
logo Start of implementation of the KSV Psych guideline

Social psychiatry in outpatient psychiatric and psychotherapeutic care

02.04.2023
logo Corona and politics: On the role of science

Comment on the start of the comment series by Prof. Dr. rer. pole. Reinhold Roski1, Prof. Dr. med. Matthias Schrappe

02.04.2023
logo On the role of clinical infectiology

Comment series part 1 by Prof. Dr. med. Matthias Schrappe

02.04.2023
logo Successful digital projects made in NRW

White paper from the “Lighthouse Digital.Medicine.NRW” initiative of the Medicine.NRW cluster

02.04.2023
Analysis of orphan drug procedures in early benefit assessment: RCTs versus best available comparative evidence

For drugs for the treatment of rare diseases (orphan drugs), the requirements of early benefit assessment according to Section 35a SGB V represent a particular challenge. The Institute for Quality and Efficiency in Health Care (IQWiG) concludes in working paper GA21-01 on orphan drugs, which are in the As part of a re-evaluation of a regular benefit assessment, the additional benefit of the initial benefit assessment for market access was fictitious.

02.04.2023
Cross-sector neighborhood care for people in old age: The CURANDUM case study

Cross-sectoral community care for the elderly: The CURANDUM case study. Life expectancy in Germany has increased significantly. The proportion of single-person households is growing, as is the shortage of skilled healthcare professionals. This is offset by changes in family and care structures, as well as the desire for an active and independent retirement in one's own home. How should older people cope with these […]

02.04.2023
Interclinical teleconsultation - opportunities and challenges

In rural areas, both patients and smaller hospitals have limited access to medical specialists. Teleconsultations are already established between resident doctors and clinics. The additional consultation paths presented here can reduce quality losses in small clinics, thereby strengthening the raison d'être of primary care providers and thus avoiding unnecessary, burdensome and costly double examinations.

02.04.2023

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.